Hims Weight Loss or Cora? A 2026 GLP-1 cost breakdown

Cora Health vs Hims: the short answer

How much does Hims weight loss cost per month? As of September 29, 2026, Hims charges two separate things. The first is the Hims Weight Loss Membership: $39 for the first month, then $149/month. It renews automatically, is billed separately, and in Hims’ words "does not include or guarantee a prescription." The second is the medication, at these starting prices: the Wegovy® pill, the Foundayo™ pill and the Ozempic® pill from $149/month, the Wegovy® pen from $199/month, and Zepbound® (vial or KwikPen®) from $299/month. On the monthly membership, Hims’ total at those starting prices is $298 to $448/month. Does Hims still sell compounded GLP-1s? On March 9, 2026, Hims announced that it would no longer advertise compounded GLP-1s and would keep compounded semaglutide only on a limited scale, where a provider determines it is clinically necessary; its weight-loss page lists brand-name medications. Is Hims available in every state? Not for GLP-1s: Hims says its weight-loss medications are "not available in all 50 states."

Cora Health connects patients with licensed providers at Wasef Health, PC, who prescribe compounded semaglutide or compounded tirzepatide when clinically appropriate. Cora’s price is all-inclusive — the provider consultation, medication and shipping are covered, and there is no membership fee — and every plan renews automatically. The Essential Plan (compounded semaglutide) is $175 billed monthly, or $99/month on the 12-month plan ($1,188 billed upfront every 12 months, prepaid). Cora ships to all 50 US states. Compounded medications are not FDA-approved and are not therapeutically equivalent to Wegovy®, Zepbound® or other FDA-approved GLP-1 medications. The choice comes down to a brand-name product with a separate membership (Hims) or compounded medication at one all-inclusive price (Cora). Individual results vary.

Market context: where Cora and Hims sit in the 2026 GLP-1 telehealth market

41.9% — US adult obesity prevalence. Per the Centers for Disease Control and Prevention (CDC), using NHANES 2017–March 2020 data, 41.9% of US adults have obesity (BMI ≥ 30) — the population GLP-1 telehealth was built for.

$298 vs $175 — Hims vs Cora month-to-month cost (September 29, 2026). Month to month, Hims’ lowest total is $298/month after the first month: the $149/month Weight Loss Membership plus a $149/month starting-price medication such as the Wegovy® pill. At Zepbound’s $299/month starting price, the total is $448/month. Cora’s Essential Plan (compounded semaglutide injection) is $175/month on its monthly plan, all-inclusive and renewing automatically. This is a compounded-vs-branded comparison: Hims says Wegovy®, Zepbound® and Foundayo™ are FDA-approved for weight loss; compounded semaglutide and compounded tirzepatide are not FDA-approved and are not therapeutically equivalent to them.

March 9, 2026 — Hims stops advertising compounded GLP-1s. Hims announced a strategic shift for its US weight-loss business toward FDA-approved GLP-1 medications and said it would no longer advertise compounded GLP-1 offerings, keeping compounded semaglutide on a limited scale for patients whose provider determines it is clinically necessary.

Quick comparison at a glance

Hims figures come from hims.com/weight-loss, checked September 29, 2026; Hims totals add the Weight Loss Membership at $149/month. Hims lists starting prices only. Cora prices are Cora’s current plan prices: prepaid plans are billed upfront, and every plan renews automatically until you cancel. Individual experiences vary. Compounded medications are not FDA-approved and are not therapeutically equivalent to the brand-name medications Hims lists.

Service and cancellation: Cora Health vs Hims Weight Loss

Price is only half the picture — how you cancel, what gets refunded, and whether a separate membership is required all shape the experience over a multi-month plan. The table below distills each platform’s published service terms. Cora’s refund terms are set out in full in its published refund policy; the Hims Weight Loss figures come from its own published terms, summarized in our step-by-step guide to canceling Hims Weight Loss. Verify the current terms on each provider’s own site before enrolling. Cora's full service and cancellation standards are published at trycora.io/service.

What changed at Hims in 2026

On March 9, 2026, Hims announced a "strategic shift" for its US weight-loss business: a focus on FDA-approved GLP-1 medications and an end to advertising compounded GLP-1 offerings, keeping compounded semaglutide on a limited scale where a provider determines it is clinically necessary.

As of September 29, 2026, Hims’ weight-loss page lists brand-name medications — the Wegovy® pill and pen, the Foundayo™ (orforglipron) pill, the Ozempic® pill, and Zepbound® in vial and KwikPen® form, among others — and states that Wegovy®, Zepbound® and Foundayo™ are FDA-approved for weight loss. Every option requires the Weight Loss Membership, and Hims notes that its GLP-1 medications are not available in all 50 states.

For patients specifically looking for compounded semaglutide or compounded tirzepatide at one all-inclusive price, Cora Health connects patients with licensed providers who can prescribe either when clinically appropriate. Neither is FDA-approved, and neither is therapeutically equivalent to the brand-name products Hims lists.

How Hims weight loss pricing works

Hims Weight Loss uses a two-part pricing structure. The figures below are from hims.com/weight-loss, checked September 29, 2026.

The first component is the Hims Weight Loss Membership: $39 for the first month, then $149/month, renewing automatically. Hims says the membership is billed separately, "does not include or guarantee a prescription," and that "medication is not available without a membership." Hims describes the membership as including a personalized treatment plan, 24/7 messaging with licensed providers, dosage adjustments, support for common side effects, in-app weight tracking, a peer community, partner discounts, and an opt-in smart scale.

The second component is the medication, billed on top at starting prices of $149/month for the Wegovy® pill, the Foundayo™ pill or the Ozempic® pill, $199/month for the Wegovy® pen, and $299/month for Zepbound® (vial or KwikPen®). Hims says the medication fee is FSA/HSA-eligible but the membership fee is not, and that insurance isn’t required.

A patient on a $149/month starting-price medication therefore pays $188 in month one ($39 membership + $149 medication) and $298/month after that. At Zepbound’s $299/month starting price, the total is $448/month after the first month.

Why Cora Health’s pricing is different

Cora Health uses an all-inclusive pricing model. The plan price is the full price: there is no separate membership, no consultation charge, no surcharge when the dose increases, and no additional shipping fee. Prepaid plans are billed upfront, and every plan renews automatically until you cancel.

Cora’s Essential Plan (compounded semaglutide):

• 12-month plan: $99/month ($1,188 billed upfront every 12 months, prepaid; renews automatically)
• 6-month plan: $120/month ($720 billed upfront every six months, prepaid; renews automatically)
• 3-month plan: $145/month ($435 billed upfront every three months, prepaid; renews automatically)
• Monthly plan: $175/month (renews automatically)

Cora Health Premium Plan (compounded tirzepatide)

Cora’s Premium Plan follows the same all-inclusive structure.

• 12-month plan: $135/month ($1,620 billed upfront every 12 months, prepaid; renews automatically)
• 6-month plan: $175/month ($1,050 billed upfront every six months, prepaid; renews automatically)
• 3-month plan: $199/month ($597 billed upfront every three months, prepaid; renews automatically)
• Monthly plan: $225/month (renews automatically)

Total cost comparison: common scenarios

Cost depends on which plan and medication each patient selects. Hims figures are from hims.com/weight-loss, checked September 29, 2026; Cora figures are Cora’s current plan prices. Each scenario compares the same billing term on both sides, or names the term. Prices may change. Compounded medications are not FDA-approved and are not therapeutically equivalent to the brand-name medications Hims lists.

• Lowest month-to-month totals: Hims $298/month after the first month ($149 membership + $149 for the Wegovy® pill, an FDA-approved tablet, at its starting price); Cora $175/month for the Essential Plan (compounded semaglutide injection), billed monthly, all-inclusive, renews automatically. They are different products: compounded semaglutide is not FDA-approved and is not therapeutically equivalent to Wegovy®.
• Zepbound® vs compounded tirzepatide, month to month: Hims $448/month after the first month ($149 membership + Zepbound® at its $299/month starting price); Cora $225/month for the Premium Plan (compounded tirzepatide), billed monthly, all-inclusive, renews automatically. Compounded tirzepatide is not FDA-approved and is not therapeutically equivalent to Zepbound®.
• Compounded semaglutide for 12 months (Cora only — Hims does not advertise compounded GLP-1s): $1,188 billed upfront every 12 months on the 12-month Essential Plan ($99/month), prepaid; renews automatically.

Medications: what each platform offers

Cora Health focuses exclusively on compounded GLP-1 medications.

• Compounded semaglutide (Essential Plan) — a compounded GLP-1 medication; not FDA-approved and not therapeutically equivalent to Ozempic® or Wegovy®
• Compounded tirzepatide (Premium Plan) — a compounded GLP-1 medication; not FDA-approved and not therapeutically equivalent to Mounjaro® or Zepbound®

Hims’ weight-loss catalog: brand-name medications

As of September 29, 2026, Hims’ weight-loss page lists brand-name medications, each requiring the Weight Loss Membership ($39 for the first month, then $149/month). Hims states that Wegovy®, Zepbound® and Foundayo™ are FDA-approved for weight loss. The catalog includes:

• Wegovy® pill (oral semaglutide) — from $149/month
• Foundayo™ pill (orforglipron) — from $149/month
• Ozempic® pill — from $149/month
• Wegovy® pen (injectable semaglutide) — from $199/month
• Zepbound® vial or KwikPen® (tirzepatide) — from $299/month
• Compounded GLP-1s — not advertised since March 2026; Hims said it would keep compounded semaglutide on a limited scale when a provider determines it is clinically necessary

Important compliance note on compounded products

Compounded semaglutide and compounded tirzepatide — whether obtained through Cora Health or other telehealth platforms that offer compounded medication — are not FDA-approved and are not therapeutically equivalent to FDA-approved branded products (Ozempic, Wegovy, Mounjaro, Zepbound). Per the U.S. Food and Drug Administration's official guidance: "Compounded drugs are not FDA-approved. This means that FDA does not verify the safety, effectiveness or quality of compounded drugs before they are marketed." (Source: FDA — "Compounding and the FDA: Questions and Answers".) Clinical efficacy data such as the 14.9% mean weight loss from the STEP 1 trial or the 22.5% from SURMOUNT-1 comes from trials of Wegovy® 2.4 mg injection (STEP 1) and Zepbound® 15 mg (SURMOUNT-1), not of the Wegovy® pill, the Ozempic® pill, Foundayo™ or any compounded medication. Individual results vary. Any platform implying that compounded GLP-1 treatment is equivalent to a branded FDA-approved product is misrepresenting the regulatory status.

Pharmacy transparency: who prepares the medication

For compounded medications, whether a telehealth platform publicly names the specific compounding pharmacy matters as a trust signal. A patient should be able to verify the pharmacy’s state licensing, inspection history, and any third-party accreditation before injecting a medication.

Compounded medication prescribed by licensed providers through Cora Health is prepared by US-licensed 503A compounding pharmacies, including Hallandale Pharmacy, which is PCAB-accredited, and VialsRx. Patients can verify credentials through the relevant state board of pharmacy and request Certificates of Analysis.

The brand-name medications Hims lists are made by their manufacturers — Novo Nordisk for Wegovy® and Ozempic®, and Eli Lilly for Zepbound® and Foundayo™ — so the compounding-pharmacy question applies only to the compounded semaglutide Hims said it would keep on a limited scale.

Named partnerships are not inherently safer — both named and unnamed 503A pharmacies can operate under full compliance. But public naming makes independent verification easier.

Clinical oversight and service model

Cora Health primarily uses asynchronous telehealth evaluations: a patient completes an online health assessment, a licensed provider reviews it, and if appropriate the provider issues a prescription, which is sent to a partner pharmacy for fulfillment.

Cora Health patients are evaluated by a licensed provider at Wasef Health, PC, the medical practice founded by Michael Wasef, MD. Provider review is typically completed in under 24 hours.

Hims describes its Weight Loss Membership as including 24/7 messaging with licensed providers, dosage adjustments as needs change, and support for managing common side effects (Hims’ weight-loss page, checked September 29, 2026).

Who should choose Cora Health

Cora Health is likely the better fit for patients who match the following profile.

• Patients who want a low all-in monthly cost for a licensed-provider compounded GLP-1 program
• Patients who prefer transparent all-inclusive pricing without a separate membership fee
• Patients across all 50 US states (Cora ships nationwide)
• Patients who are comfortable with compounded medications (not FDA-approved) and understand the regulatory distinction from branded products

Who should choose Hims

Hims is likely the better fit for patients who match the following profile.

• Patients who specifically want a brand-name GLP-1 medication (the Wegovy® pill or pen, the Foundayo™ pill, or Zepbound®) through a telehealth platform
• Patients comfortable with a membership-plus-medication pricing model, where medication is billed separately from the membership

How to switch from Hims to Cora Health

Patients currently with Hims who want a Cora Health evaluation can complete the online assessment; a licensed provider at Wasef Health, PC decides whether compounded treatment is appropriate. The specific steps depend on medication, dose, and state.

• Complete the Cora Health online health assessment at trycora.io; include your current medication, dose, and any history of side effects in the medical-history section
• A licensed provider at Wasef Health, PC reviews the assessment and determines clinical appropriateness
• If the provider prescribes treatment, a US-licensed 503A compounding pharmacy prepares and ships the medication; the pharmacies that fill Cora patients’ prescriptions include Hallandale Pharmacy and VialsRx
• Brand-name and compounded doses are not interchangeable, and there is no dose conversion between them; your provider determines the right dose based on your history.
• Note: if you were on a brand-name product through Hims, Cora Health does not offer brand-name products — the provider will discuss whether compounded semaglutide or compounded tirzepatide is appropriate for your case
• If a provider prescribes treatment and your first Cora shipment arrives, cancel the Hims Weight Loss Membership in your Hims account (see our guide to canceling Hims Weight Loss)

Frequently asked questions

Common questions about Hims Weight Loss and the Cora Health vs Hims comparison.

How much does Hims weight loss cost?

As of September 29, 2026, Hims Weight Loss costs the Weight Loss Membership — $39 for the first month, then $149/month, renewing automatically — plus the medication, billed separately: from $149/month for the Wegovy® pill, the Foundayo™ pill or the Ozempic® pill, from $199/month for the Wegovy® pen, and from $299/month for Zepbound®. After the first month, the total at those starting prices is $298 to $448/month. Hims says the membership does not include or guarantee a prescription. Cora Health’s Essential Plan (compounded semaglutide) is $175 billed monthly, or $99/month on the 12-month plan ($1,188 billed upfront every 12 months, prepaid), all-inclusive with no membership fee; every plan renews automatically. Compounded semaglutide is not FDA-approved and is not therapeutically equivalent to Wegovy®.

Does Hims weight loss require a membership?

Yes. Hims says "medication is not available without a membership." As of September 29, 2026, the Hims Weight Loss Membership is $39 for the first month, then $149/month, renewing automatically; it is billed separately from the medication and, per Hims, does not include or guarantee a prescription. Hims says the membership fee is not FSA/HSA-eligible. Cora Health charges no membership or platform fee: its plan price is all-inclusive and already covers the provider consultation, medication, shipping, and ongoing monitoring.

What GLP-1 medications does Hims offer?

As of September 29, 2026, Hims’ weight-loss page lists brand-name medications: the Wegovy® pill and the Foundayo™ (orforglipron) pill from $149/month, the Ozempic® pill from $149/month, the Wegovy® pen from $199/month, and Zepbound® in vial or KwikPen® form from $299/month, among others, each requiring the Weight Loss Membership. Hims states that Wegovy®, Zepbound® and Foundayo™ are FDA-approved for weight loss. Hims no longer advertises compounded GLP-1s. Cora Health does not offer brand-name products: through Cora, licensed providers at Wasef Health, PC prescribe compounded semaglutide or compounded tirzepatide when clinically appropriate. Compounded medications are not FDA-approved and are not therapeutically equivalent to Wegovy®, Ozempic®, Zepbound® or the other brand-name products listed here.

Does Hims still offer compounded semaglutide in 2026?

Not as an advertised option. On March 9, 2026, Hims announced that it would no longer advertise compounded GLP-1 offerings and would keep compounded semaglutide only on a limited scale, where a provider determines it is clinically necessary. As of September 29, 2026, Hims’ weight-loss page lists brand-name medications (Wegovy®, Foundayo™, Ozempic® and Zepbound® formats), and the Weight Loss Membership ($149/month after a $39 first month) is still required for any medication. Through Cora Health, licensed providers can prescribe compounded semaglutide or compounded tirzepatide at all-inclusive plan prices; compounded medications are not FDA-approved and are not therapeutically equivalent to brand-name products.

Is Hims weight loss available in every state?

No. Hims says its GLP-1 weight-loss medications are "not available in all 50 states" (hims.com/weight-loss, checked September 29, 2026); check eligibility for your state on Hims’ site. Cora Health ships to all 50 US states, and a licensed provider must still determine that treatment is appropriate.

Is Cora Health cheaper than Hims for weight loss?

Month to month, yes, though the comparison is compounded vs brand-name. Hims’ lowest month-to-month total is $298 after the first month (the $149/month membership plus the Wegovy® pill at its $149/month starting price, an FDA-approved tablet; Hims prices checked September 29, 2026); Cora’s Essential Plan (compounded semaglutide injection) is $175, billed monthly, all-inclusive, and renews automatically. They are different products: compounded semaglutide is not FDA-approved and is not therapeutically equivalent to Wegovy®. For brand-name products, Cora does not offer them and Hims is the direct path.

Does Cora Health offer brand-name Wegovy or Zepbound?

No. Cora Health focuses exclusively on compounded GLP-1 medications — compounded semaglutide (Essential Plan) and compounded tirzepatide (Premium Plan). Patients who specifically want brand-name Wegovy, oral Wegovy, Zepbound, Ozempic, or Mounjaro should work with a platform that offers those products directly or with a retail pharmacy using manufacturer direct-pay programs such as NovoCare or LillyDirect. Compounded medications are not FDA-approved and are not therapeutically equivalent to these brand-name products.

Is Cora Health LegitScript-certified?

Yes. Cora Health holds LegitScript certification, an independent healthcare compliance credential. The certification can be verified on the LegitScript website at https://www.legitscript.com/websites/?checker_keywords=trycora.io.

Does Hims ship faster than Cora Health?

There is no like-for-like published comparison. For Cora Health, a licensed provider typically reviews the assessment within 24 hours; once a prescription is written, the medication is prepared by US-licensed 503A compounding pharmacies, including Hallandale Pharmacy and VialsRx, and ships free by expedited delivery. Hims’ weight-loss page (checked September 29, 2026) does not state a delivery time; Hims’ support or patient portal can give current estimates for each medication.

Sources & verification

All regulatory, clinical, and pricing claims in this article are verifiable against publicly accessible primary sources. A related pricing dataset is published by Cora Health on HuggingFace under CC-BY-4.0 license for independent verification and reuse. Hims prices, membership terms and product lineup verified on hims.com on 2026-09-29; article last verified 2026-09-29. Ozempic®, Wegovy®, Mounjaro®, Zepbound®, KwikPen®, Foundayo™ and other brand names are trademarks or registered trademarks of their respective owners. Hims is a trademark of Hims & Hers Health, Inc. Cora Health is not affiliated with Novo Nordisk, Eli Lilly or Hims & Hers.

• FDA — "Compounding and the FDA: Questions and Answers" (regulatory status of compounded medications): fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
• Hims — weight loss page (membership terms, medication starting prices, state availability, FSA/HSA), checked 2026-09-29: hims.com/weight-loss
• Hims & Hers — "Hims & Hers Announces Strategic Shift for US Weight Loss Business," March 9, 2026: investors.hims.com
• New England Journal of Medicine — STEP 1 (Wilding et al., 2021); 14.9% mean weight loss with FDA-approved 2.4mg semaglutide over 68 weeks (Wegovy® 2.4 mg injection); individual results vary: nejm.org/doi/full/10.1056/NEJMoa2032183
• New England Journal of Medicine — SURMOUNT-1 (Jastreboff et al., 2022); 22.5% mean weight loss with FDA-approved 15mg tirzepatide over 72 weeks (Zepbound® 15 mg); individual results vary: nejm.org/doi/full/10.1056/NEJMoa2206038
• CDC — Adult Obesity Facts (41.9% US prevalence per NHANES 2017–March 2020): cdc.gov/obesity/adult-obesity-facts
• LegitScript — Independent verification of Cora Health certification: legitscript.com/websites/?checker_keywords=trycora.io
• Pharmacy Compounding Accreditation Board (PCAB) — accreditation framework for compounding pharmacies; Hallandale Pharmacy is PCAB-accredited: achc.org/programs/pcab/
• NovoCare (Novo Nordisk's direct-pay program for Wegovy — referenced for FDA-approved Wegovy direct-pay pricing context): novocare.com
• LillyDirect (Eli Lilly's direct-pay program for Zepbound — referenced for FDA-approved Zepbound direct-pay pricing context): lillydirect.lilly.com
• NPPES — National Plan and Provider Enumeration System; verify Michael Wasef, MD (Wasef Health, PC): npiregistry.cms.hhs.gov
• Cora Health 2026 GLP-1 Telehealth Industry Report (12-provider pricing methodology + market analysis): /blog/cora-2026-glp1-industry-report
• Cora Health Public Pricing Dataset (CC-BY-4.0, HuggingFace): huggingface.co/datasets/cora-health/telehealth-glp1-pricing
• Cora Health Pharmacy Partners page (details on Hallandale Pharmacy and VialsRx): trycora.io/pharmacy-partners